Nursing and Health Professions
Systematic Review
100%
Economic Evaluation
100%
Desensitization
100%
Pollen Allergy
100%
Sublingual Immunotherapy
100%
Subcutaneous Immunotherapy
91%
Meta Analysis
33%
Placebo
33%
Cost Effectiveness Analysis
25%
Allergen
16%
Palliative Therapy
16%
Cochrane Library
16%
Quality Adjusted Life Year
16%
Quality Control
8%
Drug Therapy
8%
Clinical Effectiveness
8%
Quality of Life
8%
Biomedical Technology Assessment
8%
Data Extraction
8%
Cost Utility Analysis
8%
Immunotherapy
8%
Treatment Duration
8%
Allergic Rhinitis
8%
Medicine and Dentistry
Systematic Review
100%
Desensitization
100%
Pollen Allergy
100%
Sublingual Immunotherapy
100%
Subcutaneous Immunotherapy
91%
Health Care Cost
33%
Placebo
33%
Meta-Analysis
33%
Cost-Effectiveness Analysis
25%
Allergen
16%
Symptomatic Treatment
16%
Quality Adjusted Life Year
16%
Drug Therapy
8%
Immunotherapy
8%
Quality of Life
8%
Subgroup Analysis
8%
Meta-Regression
8%
Technology Assessment
8%
Health Technology
8%
Treatment Duration
8%
Allergic Rhinitis
8%
Keyphrases
Economic Evaluation
100%
Review Evaluation
100%
Sublingual Immunotherapy
100%
Seasonal Allergic Rhinitis
100%
Cost-effectiveness
12%
Placebo
12%
Meta-analysis
12%
Quality-adjusted Life Years
8%
National Institute for Health Research
4%
Quality of Life
4%
Clinical Efficacy
4%
Subgroup Analysis
4%
Meta-analysis Regression
4%
MEDLINE
4%
Cochrane Library
4%
Meta-regression
4%
Embase
4%
Health Technology Assessment
4%
Quality Assessment
4%
Data Extraction
4%
Clinical Benefit
4%
Treatment Duration
4%
Route of Administration
4%
Patient Perspective
4%
Clinically Significant
4%
Increased Dose
4%
Randomized Placebo-controlled Trial
4%
Data Quality
4%
Cochrane Central Register of Controlled Trials
4%
Allergic Rhinitis
4%
Cost-utility
4%
Assessment Programs
4%
Evaluation Database
4%
Clinical Costs
4%
Economic Modeling
4%
Allergen
4%
Indirect Comparison
4%
Systematic Review Methods
4%
Trial Registries
4%
Evaluation Trial
4%
Indirect Comparison Meta-analysis
4%
Robust Cost
4%
Allergen-specific
4%
Comparative Effectiveness
4%
Conventional Medication
4%
New Economic Model
4%
Pharmacology, Toxicology and Pharmaceutical Science
Allergen
100%
Immunotherapy
100%
Pollen Allergy
100%
Placebo
16%
Route of Administration
4%
Allergic Rhinitis
4%